Contact
searchSearch
HMP Global

Pharmacy Learning Network

Featured

News
RSV Vaccination Averts Thousands of Severe Outcomes in First Year of US Adult Use
09/26/2025
Hannah Musick
Respiratory syncytial virus (RSV) vaccination among US adults aged 60 and older during the 2023 to 2024 season prevented an estimated 1930 deaths, 23 630 hospitalizations, and 18 326 emergency department visits—benefits that could triple with...
Respiratory syncytial virus (RSV) vaccination among US adults aged 60 and older during the 2023 to 2024 season prevented an estimated 1930 deaths, 23 630 hospitalizations, and 18 326 emergency department visits—benefits that could triple with...
Respiratory syncytial virus...
09/26/2025
Pharmacy Learning Network
News
FDA Announces Class II Recall of Bevacizumab Injection
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
Ascend Laboratories Recalls Aripiprazole Lot Nationwide Due to Superpotent Tablets
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall of Cyclobenzaprine Tablets Due to Label Mix-Up with Meloxicam
09/24/2025
Juliet Gallagher
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc....
09/24/2025
Pharmacy Learning Network
Latner Headshot
Commentary
West Virginia Sues Express Scripts Over Role in Opioid Epidemic
09/24/2025
Ann W. Latner, JD
West Virginia has joined several other states in suing the pharmacy benefit manager (PBM) Express Scripts for its alleged role in the opioid crisis. State Attorney General J.B. McCuskey announced the lawsuit, which follows similar actions...
West Virginia has joined several other states in suing the pharmacy benefit manager (PBM) Express Scripts for its alleged role in the opioid crisis. State Attorney General J.B. McCuskey announced the lawsuit, which follows similar actions...
West Virginia has joined several...
09/24/2025
Pharmacy Learning Network
Latner Headshot
Commentary
Class Action Lawsuit Filed Against Caremark Over Zepbound
09/17/2025
Ann W. Latner, JD
Two New York residents have filed a proposed class action lawsuit against the pharmacy benefit manager (PBM) Caremark over the denial of coverage for the weight-loss drug Zepbound in favor of Wegovy.
Two New York residents have filed a proposed class action lawsuit against the pharmacy benefit manager (PBM) Caremark over the denial of coverage for the weight-loss drug Zepbound in favor of Wegovy.
Two New York residents have...
09/17/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall of Zydus Succinylcholine Chloride Injection Over Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has...
09/16/2025
Pharmacy Learning Network
News
Duloxetine Capsules Recalled Over Nitrosamine Impurity
09/16/2025
Grace Taylor, MS, MA
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has...
09/16/2025
Pharmacy Learning Network
News
Sodium Bicarbonate Injection Recalled Over Arsenic Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued...
09/16/2025
Pharmacy Learning Network
Quiz
Pharmacist Sentenced for Animal Cruelty
09/15/2025
Learn more about a pharmacist who was sentenced to prison for using controlled dangerous substances to kill his dog.  
Learn more about a pharmacist who was sentenced to prison for using controlled dangerous substances to kill his dog.  
Learn more about a pharmacist...
09/15/2025
Pharmacy Learning Network
Latner Headshot
Commentary
Pharmacist Sentenced in Case Involving Dog’s Death and Misuse of Pharmaceuticals
09/15/2025
Ann W. Latner, JD
A year after deputies discovered controlled dangerous substances (CDS) in a trash can, a pharmacist was sentenced to prison for using those substances to kill his dog.
A year after deputies discovered controlled dangerous substances (CDS) in a trash can, a pharmacist was sentenced to prison for using those substances to kill his dog.
A year after deputies discovered...
09/15/2025
Pharmacy Learning Network

News

News
RSV Vaccination Averts Thousands of Severe Outcomes in First Year of US Adult Use
09/26/2025
Hannah Musick
Respiratory syncytial virus (RSV) vaccination among US adults aged 60 and older during the 2023 to 2024 season prevented an estimated 1930 deaths, 23 630 hospitalizations, and 18 326 emergency department visits—benefits that could triple with...
Respiratory syncytial virus (RSV) vaccination among US adults aged 60 and older during the 2023 to 2024 season prevented an estimated 1930 deaths, 23 630 hospitalizations, and 18 326 emergency department visits—benefits that could triple with...
Respiratory syncytial virus...
09/26/2025
Pharmacy Learning Network
News
FDA Announces Class II Recall of Bevacizumab Injection
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug Administration (FDA) has announced a nationwide Class II recall of bevacizumab (Avastin) Injection, 1.25mg/0.05mL, packaged in sterile single-dose syringes by Fagron Sterile Services, based in Wichita, Kansas.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
Ascend Laboratories Recalls Aripiprazole Lot Nationwide Due to Superpotent Tablets
09/24/2025
Juliet Gallagher
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug Administration (FDA) has announced a Class II recall involving aripiprazole tablets, USP, 10 mg in 30-count bottles.
The US Food and Drug...
09/24/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall of Cyclobenzaprine Tablets Due to Label Mix-Up with Meloxicam
09/24/2025
Juliet Gallagher
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc. has initiated a Class I recall of Cyclobenzaprine Hydrochloride Tablets, USP, 10 mg, packaged in 90-count bottles.
Unichem Pharmaceuticals USA Inc....
09/24/2025
Pharmacy Learning Network
News
FDA Issues Class II Recall of Zydus Succinylcholine Chloride Injection Over Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has voluntarily recalled multiple lots of Succinylcholine Chloride Injection after FDA testing revealed out-of-specification degradation impurities.
Zydus Pharmaceuticals has...
09/16/2025
Pharmacy Learning Network
News
Duloxetine Capsules Recalled Over Nitrosamine Impurity
09/16/2025
Grace Taylor, MS, MA
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has voluntarily recalled Duloxetine 30 mg capsules after detecting a nitrosamine impurity above interim safety limits, affecting distribution in three US states.
Breckenridge Pharmaceutical has...
09/16/2025
Pharmacy Learning Network
News
Sodium Bicarbonate Injection Recalled Over Arsenic Impurity Concerns
09/16/2025
Grace Taylor, MS, MA
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued a Class II recall of its 4.2% Sodium Bicarbonate Injection after testing revealed out-of-specification arsenic levels.
Exela Pharma Sciences has issued...
09/16/2025
Pharmacy Learning Network
News
KIMMTRAK (tebentafusp-tebn) Injection Recalled Due to Subpotency
09/10/2025
Hannah Musick
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been issued for KIMMTRAK (tebentafusp-tebn) Injection due to subpotency, potentially reducing therapeutic effectiveness in patients with metastatic uveal melanoma.
A Class II recall has been...
09/10/2025
Pharmacy Learning Network
News
Class II Recall for Multiple Strengths of Chlorpromazine Tablets Due to Contaminated Packaging Material
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Chlorpromazine Hydrochloride Tablets due to the presence of a microorganism on polyester coil packaging, posing a potential contamination risk...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network
News
FDA Issues Class I Recall for Multiple DermaRite Antiseptic and Analgesic Products Due to Dangerous Microbial Contamination
09/10/2025
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug Administration (FDA) has issued a Class I recall for multiple DermaRite antiseptic and topical products due to contamination with Burkholderia cepacia, a dangerous bacteria that poses serious infection risks to vulnerable...
The US Food and Drug...
09/10/2025
Pharmacy Learning Network

Commentary

Latner Headshot
Commentary
West Virginia Sues Express Scripts Over Role in Opioid Epidemic
09/24/2025
Ann W. Latner, JD
West Virginia has joined several other states in suing the pharmacy benefit manager (PBM) Express Scripts for its alleged role in the opioid crisis. State Attorney General J.B. McCuskey announced the lawsuit, which follows similar actions...
West Virginia has joined several other states in suing the pharmacy benefit manager (PBM) Express Scripts for its alleged role in the opioid crisis. State Attorney General J.B. McCuskey announced the lawsuit, which follows similar actions...
West Virginia has joined several...
09/24/2025
Pharmacy Learning Network
Latner Headshot
Commentary
Class Action Lawsuit Filed Against Caremark Over Zepbound
09/17/2025
Ann W. Latner, JD
Two New York residents have filed a proposed class action lawsuit against the pharmacy benefit manager (PBM) Caremark over the denial of coverage for the weight-loss drug Zepbound in favor of Wegovy.
Two New York residents have filed a proposed class action lawsuit against the pharmacy benefit manager (PBM) Caremark over the denial of coverage for the weight-loss drug Zepbound in favor of Wegovy.
Two New York residents have...
09/17/2025
Pharmacy Learning Network
Latner Headshot
Commentary
Pharmacist Sentenced in Case Involving Dog’s Death and Misuse of Pharmaceuticals
09/15/2025
Ann W. Latner, JD
A year after deputies discovered controlled dangerous substances (CDS) in a trash can, a pharmacist was sentenced to prison for using those substances to kill his dog.
A year after deputies discovered controlled dangerous substances (CDS) in a trash can, a pharmacist was sentenced to prison for using those substances to kill his dog.
A year after deputies discovered...
09/15/2025
Pharmacy Learning Network
Latner Headshot
Commentary
New York Executive Order Expands Pharmacist Authority for COVID-19 Vaccination
09/10/2025
Ann W. Latner, JD
On September 5, 2025, New York Governor Kathy Hochul signed an executive order allowing pharmacists to administer COVID-19 vaccines to those who want them.
On September 5, 2025, New York Governor Kathy Hochul signed an executive order allowing pharmacists to administer COVID-19 vaccines to those who want them.
On September 5, 2025, New York...
09/10/2025
Pharmacy Learning Network
Latner Headshot
Commentary
South Carolina Pharmacist Sentenced to Prison for Illegal Opioid Distribution
08/28/2025
Ann W. Latner, JD
A South Carolina pharmacist who had been working as a staff pharmacist for a Gastonia, North Carolina pharmacy was recently sentenced to prison time for his role in an illegal opioid distribution scheme.
A South Carolina pharmacist who had been working as a staff pharmacist for a Gastonia, North Carolina pharmacy was recently sentenced to prison time for his role in an illegal opioid distribution scheme.
A South Carolina pharmacist who...
08/28/2025
Pharmacy Learning Network
Latner Headshot
Commentary
Judge Allows Asthma Wrongful Death Suit to Continue Against PBM, Pharmacy
08/20/2025
Ann W. Latner, JD
A federal judge from the Eastern District of Wisconsin has denied a motion to dismiss in a wrongful death case that has drawn national attention.
A federal judge from the Eastern District of Wisconsin has denied a motion to dismiss in a wrongful death case that has drawn national attention.
A federal judge from the Eastern...
08/20/2025
Pharmacy Learning Network
Latner Headshot
Commentary
Federal Judge Grant Preliminary Injunction in Arkansas PBM Law Case
08/13/2025
Ann W. Latner, JD
Last month, we wrote about the CVS, Express Scripts, and Pharmaceutical Care Management Association (PCMA) lawsuit challenging Arkansas Act 624—a law prohibiting pharmacy benefit managers (PBMs) from owning or operating pharmacies in...
Last month, we wrote about the CVS, Express Scripts, and Pharmaceutical Care Management Association (PCMA) lawsuit challenging Arkansas Act 624—a law prohibiting pharmacy benefit managers (PBMs) from owning or operating pharmacies in...
Last month, we wrote about the...
08/13/2025
Pharmacy Learning Network
Latner Headshot
Commentary
Philadelphia Pharmacy Charged in $2 Million Sale of Unregulated HIV Meds
08/05/2025
Ann W. Latner, JD
Pennsylvania Attorney General Dave Sunday has announced charges against a Philadelphia pharmacy due to a criminal scheme involving unregulated HIV medications that were billed through Medicare and Medicaid.
Pennsylvania Attorney General Dave Sunday has announced charges against a Philadelphia pharmacy due to a criminal scheme involving unregulated HIV medications that were billed through Medicare and Medicaid.
Pennsylvania Attorney General...
08/05/2025
Pharmacy Learning Network
Latner Headshot
Commentary
Iowa Pharmacist Sentenced to Prison for Diverting Controlled Substances
07/30/2025
Ann W. Latner, JD
In late June 2025, pharmacist Megan Elsbury, aged 43 years, was sentenced to 1 month in federal prison. In February 2025, Elsbury pleaded guilty to 1 count of the federal charge of acquiring a controlled substance by means of...
In late June 2025, pharmacist Megan Elsbury, aged 43 years, was sentenced to 1 month in federal prison. In February 2025, Elsbury pleaded guilty to 1 count of the federal charge of acquiring a controlled substance by means of...
In late June 2025, pharmacist...
07/30/2025
Pharmacy Learning Network
Latner Headshot
Commentary
Louisiana Files 3 Lawsuits Against CVS Health, Caremark PCS
07/23/2025
Ann W. Latner, JD
Louisiana Attorney General Liz Murrill has announced the filing of 3 separate lawsuits against CVS Health Corp, CaremarkPCS Health LLC, and their affiliated entities. All 3 lawsuits allege that the corporation engaged in unfair, deceptive and...
Louisiana Attorney General Liz Murrill has announced the filing of 3 separate lawsuits against CVS Health Corp, CaremarkPCS Health LLC, and their affiliated entities. All 3 lawsuits allege that the corporation engaged in unfair, deceptive and...
Louisiana Attorney General Liz...
07/23/2025
Pharmacy Learning Network

Interviews

Vishali Amin
Interview
The State of Drug Affordability Programs and Reformation Solutions
01/29/2024
Vishali Amin, PharmD
In this interview, Vishali Amin, VP of Value Delivery at Kalderos, discusses the impact of drug affordability on Medicare patients and medical costs, as well as the barriers preventing patients from benefiting from existing programs, the need...
In this interview, Vishali Amin, VP of Value Delivery at Kalderos, discusses the impact of drug affordability on Medicare patients and medical costs, as well as the barriers preventing patients from benefiting from existing programs, the need...
In this interview, Vishali Amin,...
01/29/2024
Pharmacy Learning Network
Guy Headshot
Interview
Securing the Medical Supply Chain: Addressing RSV Drug Shortages With IoT-Enabled Condition Monitoring in the Health Care Industry
12/12/2023
Guy Yehiav
With the increase in supply chain shortages, Guy Yehiav offers expert insights into conditioning monitoring's impact on antibody drug dosages for RSV. 
With the increase in supply chain shortages, Guy Yehiav offers expert insights into conditioning monitoring's impact on antibody drug dosages for RSV. 
With the increase in supply...
12/12/2023
Pharmacy Learning Network
Interview
Systemic and Topical Treatments For Atopic Dermatitis
10/31/2023
Derek Chu, MD, PhD, FRCPC
In this feature interview, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this feature interview, Dr Derek Chu discusses systemic treatments for atopic dermatitis and also how physicians can consider the benefits and harms of prescription topical treatments.
In this feature interview, Dr...
10/31/2023
Pharmacy Learning Network
Interview
Viewpoints on Integrative Dermatology, Part 2
10/26/2023
Sarah L. Taylor, MD, MPH, BS 
In this second installment of a series exploring integrative approaches in dermatology, Dr Sarah Taylor shares her insights from 20 years of working with alternative treatments.
In this second installment of a series exploring integrative approaches in dermatology, Dr Sarah Taylor shares her insights from 20 years of working with alternative treatments.
In this second installment of a...
10/26/2023
Pharmacy Learning Network
Interview
Viewpoints on Integrative Dermatology, Part 1
10/25/2023
Peter Lio, MD, FAAD
Do you have patients asking about alternative treatment options? In this first installment of a series exploring integrative approaches in dermatology, Dr Peter Lio answers key questions to help you navigate the journey.
Do you have patients asking about alternative treatment options? In this first installment of a series exploring integrative approaches in dermatology, Dr Peter Lio answers key questions to help you navigate the journey.
Do you have patients asking...
10/25/2023
Pharmacy Learning Network
Interview
Once-Daily, Single-Tablet Combination Therapy of Macitentan, Tadalafil in the Management of Patients With PAH
10/21/2023
James F. List, MD, PhD
In this interview, James F. List, MD, PhD, Global Therapeutic Area Head, whose team oversees a portfolio of programs including Pulmonary Hypertension at Janssen Research & Development, LLC, explains the A DUE study.
In this interview, James F. List, MD, PhD, Global Therapeutic Area Head, whose team oversees a portfolio of programs including Pulmonary Hypertension at Janssen Research & Development, LLC, explains the A DUE study.
In this interview, James...
10/21/2023
Pharmacy Learning Network
Headshot of Anita Patel, PharmD, Walgreens
Interview
Impact of COVID-19 Vaccines on Patients, Health Systems
12/21/2022
Maria Asimopoulos
Anita Patel, PharmD, vice president of pharmacy service development, Walgreens, reviews the effectiveness of COVID-19 vaccines as well as the role of pharmacies in ensuring patients are vaccinated throughout the winter.
Anita Patel, PharmD, vice president of pharmacy service development, Walgreens, reviews the effectiveness of COVID-19 vaccines as well as the role of pharmacies in ensuring patients are vaccinated throughout the winter.
Anita Patel, PharmD, vice...
12/21/2022
Integrated Healthcare Executive
Headshot of Reetu Mukherji, MD, Georgetown University
Interview
Evaluating a Digital Tool for Monitoring Drug Toxicities in Patients With Colorectal Cancer
12/12/2022
Maria Asimopoulos
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD, gastrointestinal medical oncologist, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, discusses findings from her recent study which tested the feasibility of using a smartphone app to monitor...
Reetu Mukherji, MD,...
12/12/2022
Pharmacy Learning Network
Headshot of Nicole L Stout, DPT, CLT-LANA, FAPTA
Interview
Enhancing Distress Screening, Management Across Cancer Care Delivery Settings
11/23/2022
Samantha Matthews
Nicole L Stout, DPT, CLT-LANA, FAPTA, research assistant professor in the School of Medicine, Department of Hematology/Oncology, West Virginia University Cancer Institute, shares her team’s research on distress screening and a quality...
Nicole L Stout, DPT, CLT-LANA, FAPTA, research assistant professor in the School of Medicine, Department of Hematology/Oncology, West Virginia University Cancer Institute, shares her team’s research on distress screening and a quality...
Nicole L Stout, DPT, CLT-LANA,...
11/23/2022
Pharmacy Learning Network
Headshot of Safiya Karim
Interview
Discussing Association of Medical Cannabis, Prescription Opioid Use Among Patients With Cancer
10/18/2022
Edan Stanley
Safiya Karim, MD MSc FRCPC, clinical associate professor, medical oncologist, Tom Baker Cancer Centre, University of Calgary, offers insight from her team’s research on the relationship between medical cannabis and continuation of...
Safiya Karim, MD MSc FRCPC, clinical associate professor, medical oncologist, Tom Baker Cancer Centre, University of Calgary, offers insight from her team’s research on the relationship between medical cannabis and continuation of...
Safiya Karim, MD MSc FRCPC,...
10/18/2022
Pharmacy Learning Network

Podcasts

PopHealth Perspectives Stephen Crystal Part 2
PopHealth Perspectives
Addressing Prescription Drug Pricing: Fixing an Unsustainable Situation
12/28/2023
Stephen Crystal, PhD
Join us for part two of a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research...
Join us for part two of a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research...
Join us for part two of a...
12/28/2023
Pharmacy Learning Network
Crystal
Podcasts
Addressing Prescription Drug Pricing: The Urgent Need for Price Negotiation in Medicare
12/13/2023
Stephen Crystal, PhD
Join us for a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research and...
Join us for a conversation about soaring US prescription drug prices, the need for Medicare price negotiation, and proposed structural changes with Stephen Crystal, PhD, Director of the Rutgers Center for Health Services Research and...
Join us for a conversation about...
12/13/2023
Pharmacy Learning Network
Headshot of Stephanie Ostling Mason, Glytec, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Improving Glycemic Management for Better Outcomes, Cost Savings
12/07/2022
Maria Asimopoulos
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD, CDCES, diabetes clinical pharmacist, Glytec, shares the challenges associated with insulin management in the hospital setting and offers advice to improve patient outcomes.
Stephanie Ostling Mason, PharmD,...
12/07/2022
Pharmacy Learning Network
Headshot of Eric Tichy on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Drug Spending Trends: Biosimilars, COVID-19 Therapies, and More
09/28/2022
Maria Asimopoulos
Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending trends that emerged over the course of 2021 and predicts how spending will continue to change as the pandemic wanes and inflation...
Eric Tichy, PharmD, MBA, vice chair of pharmacy formulary, Mayo Clinic, offers insight into drug spending trends that emerged over the course of 2021 and predicts how spending will continue to change as the pandemic wanes and inflation...
Eric Tichy, PharmD, MBA, vice...
09/28/2022
Integrated Healthcare Executive
Headshot of Michael Ganio, ASHP, on a blue background underneath the PopHealth Perspectives logo.
Podcasts
Monkeypox Vaccines: Current Options, Considerations for Patient Education
09/28/2022
Maria Asimopoulos
Michael Ganio, PharmD, MS, senior director of pharmacy practice and quality, American Society of Health-System Pharmacists, discusses measures being taken to address the rise in monkeypox cases in the United States and reviews the efficacy of...
Michael Ganio, PharmD, MS, senior director of pharmacy practice and quality, American Society of Health-System Pharmacists, discusses measures being taken to address the rise in monkeypox cases in the United States and reviews the efficacy of...
Michael Ganio, PharmD, MS,...
09/28/2022
Pharmacy Learning Network

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
David T. Rubin, MD
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Paul Schulz, MD
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
Ronald Vender, MD, FRCPC
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
Abigail Cline, MD, PhD
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Paul Schulz, MD
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; Ryan Nix, BS, NRP, NCI
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Julie Gould
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
Videos
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
05/13/2020
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of...
05/13/2020
Pharmacy Learning Network
Videos
Diabetes - Guideline Changes, Adherence, and Newer Drug Issues
09/15/2015
09/15/2015
Pharmacy Learning Network

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use